1. Home
  2. ARWR vs KVYO Comparison

ARWR vs KVYO Comparison

Compare ARWR & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$67.01

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$32.65

Market Cap

9.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARWR
KVYO
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.8B
IPO Year
1993
2023

Fundamental Metrics

Financial Performance
Metric
ARWR
KVYO
Price
$67.01
$32.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
24
Target Price
$63.70
$43.54
AVG Volume (30 Days)
2.4M
2.1M
Earning Date
02-09-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$829,448,000.00
$1,153,988,000.00
Revenue This Year
N/A
$32.38
Revenue Next Year
N/A
$21.60
P/E Ratio
N/A
N/A
Revenue Growth
23258.15
32.81
52 Week Low
$9.57
$23.44
52 Week High
$72.36
$49.55

Technical Indicators

Market Signals
Indicator
ARWR
KVYO
Relative Strength Index (RSI) 60.22 63.90
Support Level $65.94 $28.55
Resistance Level $69.71 $33.03
Average True Range (ATR) 3.16 1.08
MACD -1.04 0.13
Stochastic Oscillator 56.15 82.00

Price Performance

Historical Comparison
ARWR
KVYO

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

Share on Social Networks: